The Week in Review: January 5 – January 12, 2018

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.

weekly_bull_sm

Friday, January 12, 2018

News Recap:

Officials warn customers of London, Ont., nail salon to get tested for HIV, hepatitis B, C. The Middlesex-London Health Unit issued an alert warning clients of Cali Nails in the White Oaks Mall that they should talk to their doctors. A customer who contracted hepatitis B went to the salon for a manicure and pedicure. The advisory is for anyone who visited the salon between May 4, 2017, and Jan. 5, 2018.

Dynavax Announces HEPLISAV-B™ is Now Available in the United States for the Prevention of Hepatitis B in Adults. HEPLISAV-B is the first and only two-dose vaccine in the U.S. for the prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older.

Brief: HCV spread from HIV-positive to HIV-negative men who have sex with men. Chronological analysis of contagiousness suggested the transmission of HCV from HIV-positive to HIV-negative patients. The authors of the study recommend that HCV surveillance should not be confined to HIV-positive MSM but should be extended to HIV-negative MSM with similar risk factors. PLoS One. There is no PrEP for HCV except safe sex!

Brief: Outcome of HBV and HCV associated HCC occurring after renal transplantation. Survival after HCC diagnosis is significantly worse in KTR (kidney transplanted) compared to nontransplanted patients with HBV and/or HCV. Prevention is crucial and should be based on viral eradication/suppression before or after transplantation. PLoS One.